FANJ
EVOK

Financial Architects (New Jersey)’s Evoke Pharma EVOK Stock Holding History

Financial Architects (New Jersey)’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15
Closed -$11K – 437
2015
Q2 		$11K Sell
15
-15
-50% -$12.8K ﹤0.01% 771
2015
Q1 		$30K Buy
+30
New +$27.1K 0.01% 485

Other funds holding EVOK

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Financial Architects (New Jersey)'s EVOK Position: Q3 2015 in Review

Financial Architects (New Jersey) sold out of Evoke Pharma (EVOK) in Q3 2015, closing a stake of 15 shares — an estimated $11K sold.

Financial Architects (New Jersey) first reported a position in EVOK in Q1 2015 and held it in 2 quarters. The position peaked at $30K in Q1 2015. 9 funds tracked by Wall St. Rank hold EVOK as of Q3 2015.

  • Financial Architects (New Jersey) reported no remaining Evoke Pharma position as of Q3 2015 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 15 Evoke Pharma shares in Q3 2015, an estimated $11K.
  • Financial Architects (New Jersey) first reported a position in Evoke Pharma in Q1 2015 and held it in 2 quarters.
  • Financial Architects (New Jersey)'s Evoke Pharma position peaked at $30K in Q1 2015.
  • 9 funds tracked by Wall St. Rank held Evoke Pharma as of Q3 2015.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2015, filed 13 Nov 2015.